The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Fowler Wyche since year 2005.
The trader's CIK number is 1301268.
At the time of this reporting, Fowler Wyche is the Director of Ziopharm Oncology Inc .
(stock ticker symbol ZIOP).
See this page for all insider trading activities at Ziopharm Oncology Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-12-11||ZIOP||Ziopharm Oncology Inc||Option Ex||20,000||2.73||54,600|
|2017-08-16||BDN||Brandywine Realty Trust||Sale||1,824||16.82||30,679|
|2017-06-12||ZIOP||Ziopharm Oncology Inc||Option Ex||15,000||4.85||72,750|
|2016-04-04||ZIOP||Ziopharm Oncology Inc||Option Ex||15,000||5.01||75,150|
|2011-08-10||ZIOP||Ziopharm Oncology Inc||Buy||5,000||5.18||25,924|
|2010-11-24||BDN||Brandywine Realty Trust||Sale||3,000||10.98||32,955|
|2009-03-31||BDN||Brandywine Realty Trust||Buy||3,842||2.60||9,996|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fowler Wyche (Director of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.